Kin-ichiro Miura

Title: Kin-ichiro Miura: Innovator in Pharmaceutical Research

Introduction

Kin-ichiro Miura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compositions for treating viral infections. With a total of 3 patents, Miura's work has had a notable impact on medical science.

Latest Patents

Miura's latest patents include a pharmaceutical composition for treating or preventing influenza. He has also developed novel capped oligonucleotides, specifically double-stranded DNA with sequences complementary to a single-stranded DNA derived from mungbean yellow mosaic virus. These innovations include double-stranded DNA characterized by having sequences complementary to a single-stranded DNA with a molecular size of about 2.67 Kb and 2.70 Kb, respectively. Each of these patents provides detailed restriction endonuclease cleavage maps, showcasing the complexity and precision of his research.

Career Highlights

Throughout his career, Miura has worked with notable organizations such as Teijin Limited and Chiba Institute of Technology. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Miura has collaborated with esteemed colleagues, including Tsuto Morinaga and Kunitada Shimotohno. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kin-ichiro Miura's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the scientific community. His work continues to influence the development of treatments for viral infections, showcasing the importance of innovation in medicine.